The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: OTHER: 2 FES-PET Imaging will be performed:
Sponsor: Institut Claudius Regaud